Angiolo Gadducci, Stefania Cosio, Antonio Fanucchi, Roberta Tana, Simona Manacorda, Sabina Pistolesi, Francesca Letizia Strigini
Journal: Anticancer research 2017;36(7):3477-82
PMID: 27354611
AIM
To assess prognosis of gestational trophoblastic neoplasia (GTN) and obstetric outcome after chemotherapy.
PATIENTS AND METHODS
Sixty-six patients had diagnosis of hydatiform mole on curettage and 18 developed GTN. Two patients were referred with pathological diagnosis of GTN. Chemotherapy was tailored according to International Federation of Gynecology and Obstetrics risk scoring system.
RESULTS
All patients with GTN but one, were recovered by chemotherapy and had no evidence of disease after a median follow-up of 80 months. Only the patient with epithelioid trophoblastic tumor died of disease. Seven out of the eight women who tried to conceive after chemotherapy became pregnant. Ten conceptions occurred, resulting in no molar pregnancy, three miscarriages and seven term-live healthy births (70.0%). All seven babies showed normal development and growth after a median follow-up of 38 months.
CONCLUSION
The prognosis of women with GTN is very good, and obstetric outcomes of those who conceive after chemotherapy are similar to those of the general population.
Copyright© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.